Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Tipus de document

Article

Versió

Versió enviada

Data de publicació

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/170234

Inhibitors of lipogenic enzymes as a potential therapy against cancer

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Cancer cells rely on several metabolic pathways such as lipid metabolism to meet the increase in energy demand, cell division, and growth and successfully adapt to challenging environments. Fatty acid synthesis is therefore commonly enhanced in many cancer cell lines. Thus, relevant efforts are being made by the scientific community to inhibit the enzymes involved in lipid metabolism to disrupt cancer cell proliferation. We review the rapidly expanding body of inhibitors that target lipid metabolism, their side effects, and current status in clinical trials as potential therapeutic approaches against cancer. We focus on their molecular, biochemical and structural properties, selectivity and effectiveness and discuss their potential role as antitumor drugs. Keywords: cancer drugs; lipid metabolism; lipogenic enzyme inhibitors.

Citació

Citació

MONTESDEOCA, Nicolás, et al. Inhibitors of lipogenic enzymes as a potential therapy against cancer. The FASEB Journal . 2020. Vol. 34, num. 9, pags. 11355-11381. ISSN 0892-6638. [consulted: 12 of August of 2026]. Available at: https://hdl.handle.net/2445/170234

Exportar metadades

JSON - METS

Compartir registre